April - June 2023 | Vol. 202
|
|
|
ADA 83rd Scientific Sessions
|
SDRI was proud to participate at the American Diabetes Association's (ADA) 83rd Scientific Sessions in San Diego, CA. The ADA Scientific Sessions unveiled cutting-edge research, treatment recommendations, and advances toward a cure for diabetes. Diabetes affects more than 37 million children and adults in the United States and 537 million around the world. The global personal and economic costs are staggering, and addressing this crisis is the core purpose of ADA's Scientific Sessions.
|
| |
|
SDRI's Work Highlighted at the NIH Artificial Pancreas Workshop
|
Dr. Kristin Castorino participated in the 5th Annual Artificial Pancreas Workshop at the NIH campus in Chicago, Illinois. SDRI's collaboration in artificial pancreas technology use during pregnancy was highlighted, and we are honored to contribute to this important conversation.
|
|
|
-
SDRI was awarded a $1.7 million grant from Eli Lilly Company for a community-based, culturally-sensitive lifestyle therapy research study to reduce obesity and type 2 diabetes burden in the LatinX population. This study will evaluate the clinical efficacy (body weight and blood sugar control) and acceptance of a novel, culturally-sensitive lifestyle intervention delivered by bilingual community health workers to LatinX adults with obesity and diabetes in Santa Barbara.
-
SDRI was awarded a NIH funded grant to evaluate the effect of moderate weight loss on sleep duration and quality in Latinos with obesity. Latinos in the U.S. are disproportionately burdened by obesity, which is a major cause of cardiometabolic diseases, including type 2 diabetes and nonalcoholic fatty liver disease in this population. Sleep and circadian disruption are independent risk factors for the development of obesity and metabolic diseases.
-
SDRI was awarded, for a second year, a NIH funded pilot and feasibility grant to develop and test a culturally tailored, dietary-lifestyle behavioral intervention that supports the increased consumption of plant-based foods and is implemented through community health workers to prevent excessive gestational weight gain and improve glycemic control in pregnant Latina women with type 2 diabetes.
|
|
|
The California Learning-Aligned Employment Program offers eligible students at public colleges and universities the opportunity to earn money to help defray their educational costs while gaining education-aligned, career-related employment. SDRI has partnered with Santa Barbara City College and students will be working at SDRI throughout 2023.
|
| |
|
SDRI will be conducting a research collaboration with Dr. Rohit Loomba, Chief of Gastroenterology and Hepatology at UCSD, on the effect of weight loss on nonalcoholic fatty liver disease in people with obesity and type 2 diabetes.
|
| |
|
Save the Date for our 4th Annual Returning to School with Diabetes Town Hall Event
|
Panelists include:
- Dr. Francine Kaufman: Pediatric Endocrinologist & Chief Medical Officer, Senseonics
- Crystal Woodward, MPS: Managing Director, American Diabetes Association Safe at School® Campaign
-
Cynthia E. Muñoz, PhD, MPH, Licensed Psychologist: Assistant Professor of Clinical Pediatrics at the University of South California’s Keck School of Medicine in Los Angeles, and Past President of Healthcare and Education, American Diabetes Association®
-
Michael Harris, PhD, Licensed Psychologist: Professor of Pediatrics, School of Medicine at OHSU, OHSU’s Novel Interventions in Children’s Healthcare Director and Founder
- Jacqueline McManemin, RN, BSN, CDE: Assistant Nurse Manager for Health Services division of Fairfax County Health Department
-
Dr. Kristin Castorino (Moderator): Senior Research Physician at SDRI
|
|
|
SDRI Appoints new Board President, Dr. Ken Waxman
|
Dr. Waxman brings a wealth of experience and expertise to this pivotal role. With a distinguished career in healthcare and a deep understanding of diabetes and its related challenges, Dr. Waxman is poised to lead SDRI into its next phase of growth and innovation.
Dr. Waxman succeeds Dr. Alex DePaoli, who has served SDRI with distinction, dedication, and unwavering commitment for 6 years as Board President. During Dr. DePaoli's tenure, SDRI achieved significant milestones in diabetes research, education, and clinical care, establishing SDRI as a global leader in diabetes research.
|
| Pictured (L to R): Dr. DePaoli, Dr. Waxman, and Dr. Klein (SDRI's Chief Scientific Officer)
|
|
|
2022 Annual Report Unveiled
|
SDRI is thrilled to unveil our 2022 Annual Report which showcases SDRI's unwavering commitment to our mission and the transformative power it holds. Additionally, the Annual Report provides a comprehensive overview of our research activities, initiatives, and accomplishments throughout the year, highlighting the incredible impact we've made together over the past year in diabetes research.
|
|
|
|
OneTalk Special Presentation
|
SDRI organized a special OneTalk discussing the Omnipod 5 Automated Insulin Delivery (AID) system care strategies along the lifecycle. This webinar served as an opportunity for attendees to explore acute and chronic changes that impact glycemia. Participants gained valuable insights into the innovative AID system's adaptability, and how to navigate the daily challenges of living with type 1 diabetes.
|
|
|
SDRI's groundbreaking research in Diabetes in Pregnancy was published in Diabetes Care. The publication highlighted that currently there are no commercially available hybrid closed-loop insulin delivery systems customized to achieve pregnancy-specific glucose targets in the U.S. This study evaluated the feasibility of at-home use of a pregnancy-specific closed-loop insulin delivery system in pregnancies complicated by type 1 diabetes. Ten participants used the system, and the results revealed reductions in hyperglycemia, hypoglycemia, or both, with 9 out of 10 participants reaching >70% of time in range for optimal blood glucose levels.
|
|
|
|
Nancy Heffron is contemporary multimedia artist who lives and works in Santa Barbara. Originals of her designs have been sold privately, displayed in numerous art exhibitions, and featured on various commercial products. This year Nancy is celebrating her 50th anniversary of living with type 1 diabetes!
|
|
|
SDRI is Recruiting for Clinical Trials
|
Automated Insulin Delivery System/Hybrid Closed-Loop Study
We are looking for adults with type 2 diabetes using insulin who are interested in artificial pancreas studies. If interested, please email Mei Mei Church, NP, at mchurch@sansum.org. Please include your phone number in your email.
Automated Insulin Delivery System/Hybrid Closed-Loop Study
We are looking for pediatric participants interested in artificial pancreas studies. If interested, please email Mei Mei Church, NP, at mchurch@sansum.org. Please include your phone number in your email.
|
|
|
Leave a Planned Gift and Make a Lasting Impact
|
By including SDRI in your estate plans, you can ensure that your passion and generosity live on, supporting the causes you care deeply about. Join us in creating a legacy of change, leaving a meaningful imprint on the lives of future generations through a planned gift that truly makes a difference. For more information, please contact Teri Creath, Planned Giving Manager, at tcreath@sansum.org or call 805-419-1338.
|
|
|
Sansum Diabetes Research Institute is dedicated to improving the lives of people impacted by diabetes through research, education, and clinical care.
|
2219 Bath St., Santa Barbara, CA 93105 | sansum.org | (805) 682-7638
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
2219 Bath Street | Santa Barbara, None 93105 US
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
|
| |
|
|
